BriaCell $BCTX secures a key international win with a new patent in New Zealand, protecting its whole-cell cancer immunotherapy tech through 2037. This strengthens its global IP and supports personalized cancer treatment. Read more:
https://feeds.issuerdirect.com/news-release.h...ymbol=BCTX